shutterstock_1515410126_mark_van_scyoc-1

Mark Van Scyoc / Shutterstock.com

27 January 2022BiotechnologyAlex Baldwin

ITC to investigate Alvotech’s Humira biosimilar

The US International Trade Commission (ITC) will investigate whether drug manufacturers used trade secrets to develop a biosimilar of AbbVie’s Humira (adalimumab).

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

AbbVie wants USITC to investigate Alvotech over Humira ‘theft’

21 December 2021 AbbVie seeks to block imports of Alvotech’s biosimilar Humira into the US, claiming that the Icelandic company plundered former employees and used its trade secrets to develop the drug.

Humira buyers appeal AbbVie ruling to Seventh Circuit

31 July 2020 Buyers of AbbVie’s arthritis treatment Humira have appealed against an Illinois judge’s decision to dismiss their class action antitrust suit to the US Court of Appeals for the Seventh Circuit.

More on this story

Biotechnology

AbbVie wants USITC to investigate Alvotech over Humira ‘theft’

21 December 2021 AbbVie seeks to block imports of Alvotech’s biosimilar Humira into the US, claiming that the Icelandic company plundered former employees and used its trade secrets to develop the drug.

Humira buyers appeal AbbVie ruling to Seventh Circuit

31 July 2020 Buyers of AbbVie’s arthritis treatment Humira have appealed against an Illinois judge’s decision to dismiss their class action antitrust suit to the US Court of Appeals for the Seventh Circuit.

More on this story

Biotechnology

AbbVie wants USITC to investigate Alvotech over Humira ‘theft’

21 December 2021 AbbVie seeks to block imports of Alvotech’s biosimilar Humira into the US, claiming that the Icelandic company plundered former employees and used its trade secrets to develop the drug.

Humira buyers appeal AbbVie ruling to Seventh Circuit

31 July 2020 Buyers of AbbVie’s arthritis treatment Humira have appealed against an Illinois judge’s decision to dismiss their class action antitrust suit to the US Court of Appeals for the Seventh Circuit.

More features

LSPN: Using ‘the patentee’s friend’ in Section 112 claims

ResMed voids sleep apnoea tech patent at PTAB

Novartis settles with licensee of blood cancer therapy day before trial

Foley adds five-partner team from Perkins Coie and K&L Gates

UPC orders 17-country ban on EOFlow's pumps in Insulet feud

US warns of rising counterfeit drug threat from India and China

Judge denies Pfizer and BioNTech bid to see off COVID-19 vaccine suit

Biotech and healthcare expert returns to Latham & Watkins